Celcuity Inc. Gains 22.03%
Wed, Nov 11, 2020 at 05:30 PM
Celcuity Inc. (CELC:NASDAQ) rocketted at $6.98, representing a gain of 22%. On Tue 10 Nov 20, CELC:NASDAQ hit a New 2-Week Intraday High of $6.19. The stock got featured on our News Catalysts scanner on Tue 10 Nov 20 at 08:37 AM in the 'EARNINGS' category. From Tue 27 Oct 20, the stock recorded 55.56% Up Days and 70.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Celcuity Inc. (CELC:NASDAQ)
Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
Top 10 Gainers:
- Five Prime Therapeutics, Inc. (FPRX:NASDAQ), 237.08%
- Fuel Tech, Inc. (FTEK:NASDAQ), 64.26%
- Equillium, Inc. (EQ:NASDAQ), 44.83%
- GRAY (GRAY:NASDAQ), 35.27%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 34.66%
- Genfit SA (GNFT:NASDAQ), 28.79%
- Immuron Limited (IMRN:NASDAQ), 24.44%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 24.02%
- Revlon, Inc. (REV:NYSE), 22.53%
- Celcuity Inc. (CELC:NASDAQ), 22.03%